Cosmos Health Inc. (Nasdaq: COSM)

Robotic automation, smart logistics, and ongoing facility upgrades are fueling strong momentum at our pharmaceutical wholesale subsidiary, Cosmofarm, as record performance continues with accelerating customer growth, improving unit economics, and expanded delivery routes. $COSM

@CosmosHealthInc provides update: -To issue updated guidance following FY25 results -Record growth continues -Significant US expansion underway -Important R&D updates anticipated -Evaluating options to address valuation disconnect, incl. buybacks $COSM globenewswire.com/news-release/2…

Our Cana manufacturing facility plays a key role in our vertically integrated platform. EU-GMP and EMA-certified, it supports pharmaceuticals, nutraceuticals, cosmetics and medical devices, positioning us for scalable contract manufacturing growth. $COSM

@CosmosHealthInc purchases $600,000 in Bitcoin. Investment in digital assets has reached $3.1 million, reflecting the combined value of its holdings in Bitcoin and Ethereum. $COSM $BTC $ETH globenewswire.com/news-release/2…

@CosmosHealthInc has entered into an LOI to acquire an extensive $11.5 million pharmacy distribution network from an established pharmaceutical company that has been serving the Greek market for nearly 40 years. $COSM globenewswire.com/news-release/2…

@CosmosHealthInc appoints globally recognized AI-driven drug discovery and clinical-stage biotech expert Dr. Dimitrios Iliopoulos to the Advisory Board.  $COSM globenewswire.com/news-release/2…

@CosmosHealthInc highlights ~$15 million fair market value of real estate assets,  exceeding current market capitalization. Evaluating strategic monetization options to address significant discount to book value and unlock shareholder value. $COSM globenewswire.com/news-release/2…

@CosmosHealthInc continues to expand its UK retail footprint, with C-Scrub now also available through Superdrug, the UK’s second-largest beauty and health retailer. $COSM globenewswire.com/news-release/2…

@CosmosHealthInc announced a significant expansion of its UK retail footprint, with its antimicrobial skin cleanser C-Scrub now available through Tesco, the UK’s largest retailer, which holds nearly 30% market share. 🇬🇧 $COSM globenewswire.com/news-release/2…

@CosmosHealthInc participated in the World Health Expo Dubai 2026 @expocitydubai, one of the world’s largest healthcare gatherings, where it showcased its expanding brand portfolio, including Sky Premium Life, C-Scrub, and Mediterranation. $COSM globenewswire.com/news-release/2…

Last day at the World Health Expo Dubai 2026 @expocitydubai. We are truly pleased by the warm reception our brands have received throughout the exhibition. Thank you to everyone who visited us and took the time to connect. $COSM #WorldHealthExpo #ExpoCityDubai

@CosmosHealthInc expands its digital assets program with a $500,000 Bitcoin purchase, bringing total cryptocurrency investments to $2.5 million. The Company is also evaluating the inclusion of other select cryptocurrencies. $COSM $BTC $ETH globenewswire.com/news-release/2…

@CosmosHealthInc is participating in World Health Expo Dubai 2026 (Feb 9–12) at the Dubai Exhibition Centre, @expocitydubai, showcasing its expanding portfolio of proprietary brands, led by its flagship Sky Premium Life nutraceutical line. Visit us at Booth SA.A79.

Our antiseptic wash C-Scrub delivers reliable antimicrobial properties, supporting effective bacteria reduction. Designed to support comprehensive hand & skin hygiene, C-Scrub is available across multiple sales channels, including major retailers and e-commerce platforms. $COSM

Our Sky Premium Life brand is expanding globally, built on premium formulations, with diverse categories from beauty and women’s wellness to immune system support and joint & bone health — available via pharmacies, retail chains, and e-commerce platforms. $COSM

Cosmofarm continues its record momentum, reflecting strong execution across customer acquisition, improving unit economics & operational efficiency. Our robotic investments expand capacity to support incremental annual revenue potential of ~$40M $COSM globenewswire.com/news-release/2…

@CosmosHealthInc subsidiary Cosmofarm announces accelerating customer growth, improving unit economics, and robotic expansion, supporting incremental annual revenue potential of approximately $40 million. $COSM #CosmosHealth globenewswire.com/news-release/2…

I am pleased @ZacksSmallCap initiated coverage on $COSM with a valuation of $4.5/share, recognizing the transformation across our group. This coverage underscores the strength of our vertically integrated model, accelerating growth & importance of our investments from $ETH to #AI

Zacks Small-Cap Research has initiated coverage on @CosmosHealthInc with a valuation of $4.50 per share. $COSM #CosmosHealth globenewswire.com/news-release/2…

R&D is in our DNA. Our Cloudscreen platform leverages AI-driven drug repurposing to identify new therapeutic patterns and pathways, supporting patent generation, accelerating research efficiency, and advancing data-driven innovation in healthcare 💡. $COSM #AI #RnD